Literature DB >> 21484130

Renal function and severity of bright liver. Relationship with insulin resistance, intrarenal resistive index, and glomerular filtration rate.

Daniela Catalano1, Guglielmo M Trovato, Giuseppe Fabio Martines, Clara Pirri, Francesca M Trovato.   

Abstract

AIMS: Relationships of renal function and liver disease are described in acute and chronic liver failure. The aim of the study is to investigate which relationship, if any, is present between severity of non-alcoholic fatty liver disease (NAFLD), assessed by bright liver score (BLS) versus mild-moderate renal insufficiency assessed by glomerular filtration rate (GFR) and by ultrasound intra-renal arterial resistive index (RRI). Moreover, which difference, if any, can be found in NAFLD patients with normal versus increased transaminases. PATIENTS: The study enrolled 323 NAFLD and 176 non-NAFLD consecutive patients, comparable for age, gender distribution, GFR, and RRI referred to a university clinical day hospital after an ultrasound diagnosis of bright liver, for clinical-nutritional counselling. Personalized computerized mediterranean diet, physical activity increase, and smoking withdrawal integrated counselling were provided.
RESULTS: In NAFLD patients, homoeostasis model (HOMA) has a significant correlation with BLS. According to the severity of BLS, grade II-III versus grade I patients have significantly higher values of HOMA, body mass index (BMI), triglycerides, and longitudinal right liver length. By odds ratio, more severe BLS, increased HOMA, and transaminases are associated with lower GFR. Increased transaminases are associated with higher grades of BLS, HOMA, and BMI. By multiple linear regression waist-to-hip ratio, RRI, and BLS, as significant independent factors (p < 0.0001), explain significantly variance to GFR. This is not observed in normal control group, in which only RRI is a factor explaining GFR.
CONCLUSION: Greater RRI, abdominal obesity, and greater BLS account for a lower GFR in NAFLD patients suggesting the hypothesis that inter-related factors can be operating early in the natural history of obesity-related kidney and liver disease.

Entities:  

Year:  2011        PMID: 21484130     DOI: 10.1007/s12072-011-9254-2

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  42 in total

Review 1.  Synergy of low nephron number and obesity: a new focus on hyperfiltration nephropathy.

Authors:  Manuel Praga
Journal:  Nephrol Dial Transplant       Date:  2005-10-13       Impact factor: 5.992

2.  Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease.

Authors:  Martin K Rutter; Peter W F Wilson; Lisa M Sullivan; Caroline S Fox; Ralph B D'Agostino; James B Meigs
Journal:  Circulation       Date:  2008-02-04       Impact factor: 29.690

Review 3.  Insulin resistance, diabetes and cardiovascular risk: approaches to treatment.

Authors:  Daniel E Rosenberg; Serge A Jabbour; Barry J Goldstein
Journal:  Diabetes Obes Metab       Date:  2005-11       Impact factor: 6.577

4.  Pathogenetic background for treatment of ascites and hepatorenal syndrome.

Authors:  Søren Møller; Jens H Henriksen; Flemming Bendtsen
Journal:  Hepatol Int       Date:  2008-09-20       Impact factor: 6.047

5.  Renal functional reserve in obesity hypertension.

Authors:  I M D Pecly; V Genelhu; E A Francischetti
Journal:  Int J Clin Pract       Date:  2006-10       Impact factor: 2.503

6.  Combined renal effects of overweight and hypertension.

Authors:  J Ribstein; G du Cailar; A Mimran
Journal:  Hypertension       Date:  1995-10       Impact factor: 10.190

7.  Hemodynamic studies in acute-on-chronic liver failure.

Authors:  Ashish Kumar; Kunal Das; Praveen Sharma; Vimal Mehta; Barjesh Chander Sharma; Shiv Kumar Sarin
Journal:  Dig Dis Sci       Date:  2008-08-09       Impact factor: 3.199

8.  Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.

Authors:  Maud Lemoine; Vlad Ratziu; Minji Kim; Mustapha Maachi; Dominique Wendum; François Paye; Jean Philippe Bastard; Raoul Poupon; Chantal Housset; Jacqueline Capeau; Lawrence Serfaty
Journal:  Liver Int       Date:  2009-04-24       Impact factor: 5.828

9.  The effects of weight loss on renal function in patients with severe obesity.

Authors:  Avry Chagnac; Tali Weinstein; Michal Herman; Judith Hirsh; Uzi Gafter; Yaacov Ori
Journal:  J Am Soc Nephrol       Date:  2003-06       Impact factor: 10.121

10.  Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.

Authors:  Wolfram Goessling; Joseph M Massaro; Ramachandran S Vasan; Ralph B D'Agostino; R Curtis Ellison; Caroline S Fox
Journal:  Gastroenterology       Date:  2008-09-20       Impact factor: 22.682

View more
  5 in total

1.  Behavior, nutrition and lifestyle in a comprehensive health and disease paradigm: skills and knowledge for a predictive, preventive and personalized medicine.

Authors:  Guglielmo M Trovato
Journal:  EPMA J       Date:  2012-03-22       Impact factor: 6.543

Review 2.  ADV36 adipogenic adenovirus in human liver disease.

Authors:  Francesca M Trovato; Daniela Catalano; Adriana Garozzo; G Fabio Martines; Clara Pirri; Guglielmo M Trovato
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

3.  Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study.

Authors:  Vassilios G Athyros; Olga Giouleme; Emmanouel S Ganotakis; Moses Elisaf; Konstantinos Tziomalos; Themistoklis Vassiliadis; Evangelos N Liberopoulos; Eleni Theocharidou; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  Arch Med Sci       Date:  2011-11-08       Impact factor: 3.318

Review 4.  4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.

Authors:  Francesca Maria Trovato; Daniela Catalano; Giuseppe Musumeci; Guglielmo M Trovato
Journal:  EPMA J       Date:  2014-12-07       Impact factor: 6.543

5.  Liver parameters as part of a non-invasive model for prediction of all-cause mortality after myocardial infarction.

Authors:  Theodor Baars; Jan-Peter Sowa; Ursula Neumann; Stefanie Hendricks; Mona Jinawy; Julia Kälsch; Guido Gerken; Tienush Rassaf; Dominik Heider; Ali Canbay
Journal:  Arch Med Sci       Date:  2018-05-15       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.